Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
about
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary diseaseCombined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseCombination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary diseaseCombination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary diseasePositioning new pharmacotherapies for COPDCombination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseThe efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methodsComparison of Korean COPD guideline and GOLD initiative report in term of acute exacerbation: a validation study for Korean COPD guideline.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trialEfficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia.Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treEmergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified?Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 studyA Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993.Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease.An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.Long-acting muscarinic antagonists.Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies.Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study.Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial.Tailoring of corticosteroids in COPD management.Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life.Recommendations for the pharmacological treatment of COPD: questions and answers.Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.Triple Therapy in COPD: What We Know and What We Don't.Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects.Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol.
P2860
Q24199130-650FF4D7-291D-46DD-8A39-89FA4A07FB25Q24202510-8A0415B9-E202-4DDE-A5E3-0284557FFDD5Q24202744-34B0D1D3-0F16-440E-948E-286D9BCC0A1DQ26471530-FE5FF1A0-A7B5-4555-ADDD-F80417794671Q26798659-82A44B89-22F0-4F3B-BFAF-4D95316CAC7AQ27012625-701EBB15-E15C-43E2-8E72-B368B1C0750DQ28085193-75B5C41A-594A-42AE-8017-00E14339544EQ34029980-212A53A1-D090-437D-8492-91AD1291AF85Q34550471-C559AB13-9B7F-42E7-A274-506CB5810D34Q35595077-65CC2A3A-BF4A-4413-9777-5912424712F6Q35783948-A8D1600F-A0FF-42FC-93E5-29B58F0E23D1Q36265120-5CB14EBF-CD41-4061-94E5-CB6C7F70659AQ36652471-028C9318-8D09-4EC9-AF59-2B745A53389BQ36704580-DC398B5B-710C-4E23-A637-B10172556F39Q37177278-7B9D51B5-0E49-438E-A74E-C492EEF48061Q37533170-6B4D7603-9F8C-4A57-98CD-F1FCA54DEAB0Q37685496-206BE87D-B274-491F-8FD6-DC299B916776Q38125210-F92D62F8-545F-4EC1-8DB3-EF8B1E42111EQ38399184-E8F85784-064B-4372-AD32-21249947CB8BQ38537326-59D04A90-7DCA-4891-B208-11DF116C016FQ40449015-E2D160F4-17C3-4925-96B7-33E090A555CDQ41018618-94F8EFDB-091E-4BAE-81A2-2E7497BA0424Q41400495-4DC785A2-9E7D-4DA9-8866-E66AC090E475Q41844550-63BE660A-4077-4DE5-8CC6-DCA17A68F993Q42753079-2659B0B7-F786-49D4-A2F4-3E83F4108B00Q47192702-9F281BD0-942E-4699-879F-5782A90C21B5Q47272746-EAC9CD1C-7041-4C2E-A523-468F8AD4B856Q47647326-72A3D303-D8F2-4A90-9383-29638A74A966Q47984024-673BA6B5-8D5E-42D1-BDE5-81C72771AAB9Q48335044-CF28E574-98F2-4811-87D8-38354229D2C8Q55335157-1322093B-A361-4360-8BBC-C2603F86C38EQ55360310-F370E40E-CB54-4DBD-B531-F3E0A3B07A40
P2860
Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Comparison of tiotropium plus ...... a randomized controlled study.
@en
type
label
Comparison of tiotropium plus ...... a randomized controlled study.
@en
prefLabel
Comparison of tiotropium plus ...... a randomized controlled study.
@en
P2093
P1433
P1476
Comparison of tiotropium plus ...... a randomized controlled study.
@en
P2093
Hwa Sik Moon
Hye Yun Park
Jae-Jeong Shim
Jee-Hong Yoo
Ki Suck Jung
Korea Chronic Obstructive Pulmonary Disease study group
Korean Academy of Tuberculosis and Respiratory Diseases study group
Kwan Ho Lee
Sang Do Lee
Se Kyu Kim
P304
P356
10.1016/J.RMED.2011.09.004
P577
2011-10-04T00:00:00Z